— Know what they know.
/
Not Investment Advice

BCRX NASDAQ

BioCryst Pharmaceuticals, Inc.
1W: -12.5% 1M: -7.1% 3M: +12.3% YTD: +11.6% 1Y: -19.0% 3Y: -1.1% 5Y: -34.8%
$8.29
-0.08 (-0.96%)
 
Weekly Expected Move ±7.9%
$8 $8 $9 $10 $10
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 37 · $1.7B mcap · 182M float · 3.04% daily turnover · Short 49% of daily vol
Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings
Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest Supply Chain

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
38.8 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: -361.6%
Cost Advantage ★
56
Intangibles
22
Switching Cost
53
Network Effect
37
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. BCRX has No discernible competitive edge (38.8/100). The business operates without significant structural advantages. The primary source of advantage is Cost Advantage. Negative ROIC of -361.6% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$14
Avg Target
$14
High
Based on 5 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 25Hold: 4Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$14.40
Analysts5
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2025-11-05 JMP Securities Jonathan Wolleben Initiated $25 — +258.7% $6.97
2025-11-04 Barclays — $7 $9 +2 +31.2% $6.86
2025-10-14 RBC Capital — Initiated $15 — +133.6% $6.42
2025-10-14 Jefferies Maury Raycroft $11 $15 +4 +133.6% $6.42
2025-10-01 Evercore ISI — $16 $8 -8 +10.5% $7.24
2024-08-06 Barclays Gena Wang $14 $7 -7 -6.8% $7.51
2024-08-05 Jefferies Maury Raycroft $19 $11 -8 +46.5% $7.51
2022-11-02 Evercore ISI Liisa Bayko Initiated $16 — +29.2% $12.38
2022-08-23 Barclays Gena Wang Initiated $14 — -2.3% $14.32
2022-01-09 Cowen & Co. Ken Cacciatore Initiated $25 — +69.1% $14.78
2021-11-02 Cantor Fitzgerald Brian Cheng Initiated $21 — +69.4% $12.40
2021-08-08 Jefferies Maury Raycroft Initiated $19 — +7.6% $17.65

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B-
May 22, 2026
DCF
5
ROE
5
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. BCRX receives an overall rating of B-. Strongest factors: DCF (5/5), ROE (5/5). Areas of concern: ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-05-18 C+ B-
2026-05-08 B- C+
2026-05-06 B B-
2026-04-24 B- B
2026-03-17 B B-
2026-03-12 B- B
2026-03-11 B B-
2026-03-04 B- B
2026-03-02 B B-
2026-02-26 C+ B

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 30 Grade D
Profitability
0
Balance Sheet
36
Earnings Quality
30
Growth
52
Value
32
Momentum
50
Safety
0
Cash Flow
70
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. BCRX scores highest in Cash Flow (70/100) and lowest in Profitability (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-2.14
Distress Zone
Piotroski F-Score
4/9
✗ ✓ ✗ ✓ ✓ ✗ ✗ ✗ ✓
Beneish M-Score
-9.40
Unlikely Manipulator
Ohlson O-Score
-2.37
Bankruptcy prob: 8.6%
Low Risk
Credit Rating
B-
Score: 20.0/100
Trend: Stable
Earnings Quality
—
OCF/NI: -0.65x
Accruals: -150.2%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. BCRX scores -2.14, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. BCRX scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. BCRX's score of -9.40 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. BCRX's implied 8.6% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. BCRX receives an estimated rating of B- (score: 20.0/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-4.39x
PEG
0.00x
P/S
1.96x
P/B
-3.63x
P/FCF
7.86x
P/OCF
7.78x
EV/EBITDA
-6.69x
EV/Revenue
2.83x
EV/EBIT
-6.61x
EV/FCF
8.55x
Earnings Yield
-19.86%
FCF Yield
12.73%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. BCRX currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.008
NI / EBT
×
Interest Burden
1.196
EBT / EBIT
×
EBIT Margin
-0.429
EBIT / Rev
×
Asset Turnover
1.763
Rev / Assets
×
Equity Multiplier
-1.688
Assets / Equity
=
ROE
153.9%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. BCRX's ROE of 153.9% is driven by Asset Turnover (1.763), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.01 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$8.29
Median 1Y
$6.18
5th Pctile
$1.76
95th Pctile
$21.71
Ann. Volatility
77.9%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Jon P. Stonehouse
Former President and Chief Executive Officer
 $728,466 $— $12,951,082
Charles K. Gayer
President and Chief Executive Officer; Former Chief Commercial Officer
 $609,397 $3,358,230 $9,627,868
Babar Ghias Financial
ancial Officer
 $271,515 $2,124,571 $6,748,152
Alane P. Barnes
Chief Legal Officer and Corporate Secretary
 $542,519 $867,721 $5,616,032
Helen M. Thackray,
M.D. Former Chief R&D Officer
 $425,999 $1,168,791 $4,339,624
Anthony J. Doyle
Former Chief Financial Officer and Treasurer
 $151,925 $708,694 $2,141,135

CEO Pay Ratio

16:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $12,951,082
Avg Employee Cost (SGA/emp): $801,487
Employees: 435

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
435
-25.0% YoY
Revenue / Employee
$2,011,120
Rev: $874,837,000
Profit / Employee
$606,577
NI: $263,861,000
SGA / Employee
$801,487
Avg labor cost proxy
R&D / Employee
$381,899
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -22.5% -23.9% 2.9% 3.1% 3.3% 3.1% 1.2% 1.1% 1.2% 1.2% 60.4% 55.6% 38.9% 33.0% 19.1% 11.5% 7.7% 1.9% -88.7% 1.5% 1.54%
ROA -84.0% -88.9% -39.9% -42.0% -45.4% -41.9% -43.4% -39.8% -42.7% -41.5% -42.5% -39.1% -27.4% -23.2% -17.6% -10.6% -7.1% -1.7% 52.5% -91.2% -91.18%
ROIC 3.5% 3.5% 6.6% 6.5% 6.7% 5.7% -5.2% -4.4% -4.0% -3.8% 4.2% 3.7% 2.5% 1.7% -4.5% 59.0% 96.4% 1.4% 4.0% -3.6% -3.62%
ROCE -78.1% -78.9% -25.3% -25.0% -25.9% -20.0% -32.7% -27.1% -29.7% -28.0% -32.2% -28.1% -12.4% -6.9% 3.5% 14.0% 18.8% 25.0% 1.1% -1.2% -1.19%
Gross Margin 99.3% 98.5% 99.1% 99.5% 99.6% 95.2% 96.9% 98.6% 98.8% 98.7% 98.2% 98.6% 98.4% 97.2% 95.3% 96.9% 98.3% 98.4% 97.6% -3.5% -3.50%
Operating Margin -59.2% -1.1% -1.1% -1.0% -53.0% -23.0% -58.2% -41.3% -25.1% -13.7% -45.7% -15.6% 8.0% 6.6% -3.4% 14.6% 18.2% 18.6% 64.0% -4.5% -4.49%
Net Margin -86.5% -1.4% -37.7% -1.5% -89.8% -56.1% -89.9% -77.5% -91.3% -41.7% -66.1% -38.1% -11.6% -12.0% -20.4% 0.0% 3.1% 8.1% 60.5% -4.6% -4.61%
EBITDA Margin -59.1% -1.1% 7.3% -99.7% -51.3% -20.9% -56.1% -36.1% -54.9% -9.3% -40.9% -11.0% 11.5% 10.0% -0.9% 16.9% 17.4% 20.2% 65.5% -4.5% -4.49%
FCF Margin -2.2% -1.4% -92.0% -86.0% -80.3% -72.3% -60.3% -45.8% -40.4% -35.3% -29.4% -29.1% -22.4% -13.7% -11.8% -5.3% 2.8% 7.9% 37.5% 33.1% 33.15%
OCF Margin -2.1% -1.4% -90.4% -84.5% -79.2% -71.5% -59.8% -45.4% -40.0% -34.7% -28.7% -28.5% -21.9% -13.5% -11.5% -5.1% 3.0% 8.3% 37.8% 33.5% 33.45%
ROA 3Y Avg snapshot only -46.78%
ROIC Economic snapshot only -88.60%
Cash ROA snapshot only 57.63%
Cash ROIC snapshot only 3.55%
CROIC snapshot only 3.52%
NOPAT Margin snapshot only -34.06%
Pretax Margin snapshot only -51.28%
R&D / Revenue snapshot only 21.36%
SGA / Revenue snapshot only 40.73%
SBC / Revenue snapshot only 10.60%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -13.15 -11.35 -13.68 -15.50 -9.37 -12.13 -8.68 -6.95 -5.49 -5.68 -5.33 -5.02 -8.74 -12.70 -17.55 -30.19 -55.17 -190.10 6.48 -5.04 -4.385
P/S Ratio 35.59 22.57 16.02 15.99 9.64 9.84 7.92 5.43 4.34 4.23 3.64 2.95 3.34 3.81 3.46 3.21 3.53 2.78 1.95 2.60 1.965
P/B Ratio -146.20 -133.62 -23.54 -28.10 -18.35 -21.93 -7.28 -5.34 -4.52 -4.56 -2.65 -2.30 -2.80 -3.45 -3.28 -3.39 -4.14 -3.51 -14.35 -19.36 -3.626
P/FCF -16.51 -16.52 -17.42 -18.60 -12.02 -13.61 -13.15 -11.85 -10.74 -11.97 -12.40 -10.11 -14.87 -27.72 -29.34 -60.05 125.00 35.25 5.21 7.86 7.856
P/OCF — — — — — — — — — — — — — — — — 117.15 33.59 5.17 7.78 7.783
EV/EBITDA -15.69 -14.19 -21.39 -25.70 -16.47 -25.38 -17.12 -15.88 -12.63 -13.52 -14.12 -14.59 -39.03 -83.29 162.39 44.86 39.26 26.10 5.44 -6.69 -6.693
EV/Revenue 35.32 22.39 16.57 16.44 10.07 10.20 9.09 6.52 5.38 5.23 4.96 4.17 4.48 4.87 4.61 4.24 4.47 3.65 2.19 2.83 2.833
EV/EBIT -15.63 -14.13 -21.26 -25.51 -16.33 -25.06 -16.95 -15.68 -12.47 -13.34 -13.92 -14.37 -37.76 -78.85 179.89 46.09 40.07 26.51 5.52 -6.61 -6.609
EV/FCF -16.39 -16.39 -18.02 -19.13 -12.54 -14.10 -15.09 -14.24 -13.30 -14.79 -16.88 -14.32 -19.95 -35.41 -39.14 -79.41 158.02 46.24 5.82 8.55 8.546
Earnings Yield -7.6% -8.8% -7.3% -6.5% -10.7% -8.2% -11.5% -14.4% -18.2% -17.6% -18.8% -19.9% -11.4% -7.9% -5.7% -3.3% -1.8% -0.5% 15.4% -19.9% -19.86%
FCF Yield -6.1% -6.1% -5.7% -5.4% -8.3% -7.3% -7.6% -8.4% -9.3% -8.4% -8.1% -9.9% -6.7% -3.6% -3.4% -1.7% 0.8% 2.8% 19.2% 12.7% 12.73%
PEG Ratio snapshot only 0.000
EV/OCF snapshot only 8.467
EV/Gross Profit snapshot only 14.993
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 3.06 3.06 5.46 5.46 5.46 5.46 4.90 4.90 4.90 4.90 3.31 3.31 3.31 3.31 2.63 2.63 2.63 2.63 2.06 2.06 2.062
Quick Ratio 3.00 3.00 5.31 5.31 5.31 5.31 4.63 4.63 4.63 4.63 3.12 3.12 3.12 3.12 2.58 2.58 2.58 2.58 2.03 2.03 2.035
Debt/Equity -14.51 -14.51 -5.55 -5.55 -5.55 -5.55 -2.52 -2.52 -2.52 -2.52 -1.81 -1.81 -1.81 -1.81 -1.77 -1.77 -1.77 -1.77 -4.01 -4.01 -4.006
Net Debt/Equity — — — — — — — — — — — — — — — — — — — — —
Debt/Assets 0.84 0.84 1.01 1.01 1.01 1.01 1.35 1.35 1.35 1.35 1.60 1.60 1.60 1.60 1.72 1.72 1.72 1.72 0.93 0.93 0.928
Debt/EBITDA -1.57 -1.55 -4.87 -4.93 -4.77 -6.19 -5.15 -6.23 -5.68 -6.04 -7.09 -8.12 -18.81 -34.22 65.69 17.68 13.26 10.03 1.36 -1.27 -1.273
Net Debt/EBITDA 0.12 0.12 -0.70 -0.71 -0.69 -0.89 -2.20 -2.67 -2.43 -2.58 -3.75 -4.29 -9.94 -18.09 40.63 10.93 8.20 6.20 0.58 -0.54 -0.540
Interest Coverage -5.07 -3.92 -2.07 -1.73 -1.55 -1.06 -1.47 -1.17 -1.23 -1.13 -1.09 -0.98 -0.45 -0.26 0.12 0.48 0.66 0.93 4.39 -5.05 -5.051
Equity Multiplier -17.38 -17.38 -5.50 -5.50 -5.50 -5.50 -1.87 -1.87 -1.87 -1.87 -1.13 -1.13 -1.13 -1.13 -1.03 -1.03 -1.03 -1.03 -4.32 -4.32 -4.315
Cash Ratio snapshot only 1.401
Debt Service Coverage snapshot only -4.988
Cash to Debt snapshot only 0.576
FCF to Debt snapshot only 0.615
Defensive Interval snapshot only 253.4 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.31 0.45 0.34 0.41 0.44 0.52 0.48 0.51 0.54 0.56 0.62 0.67 0.72 0.77 0.89 1.00 1.11 1.19 1.74 1.76 1.763
Inventory Turnover 2.24 1.98 0.64 0.14 0.13 0.40 0.30 0.34 0.37 0.25 0.17 0.18 0.20 0.28 0.67 0.85 0.91 0.87 2.94 106.54 106.544
Receivables Turnover 5.14 7.41 8.26 9.88 10.70 12.53 6.77 7.24 7.66 7.94 6.16 6.61 7.11 7.67 6.63 7.40 8.20 8.82 9.41 9.53 9.530
Payables Turnover 0.48 0.43 0.31 0.07 0.07 0.19 0.31 0.35 0.38 0.26 0.26 0.28 0.33 0.44 0.76 0.96 1.03 0.98 1.44 52.30 52.302
DSO 71 49 44 37 34 29 54 50 48 46 59 55 51 48 55 49 45 41 39 38 38.3 days
DIO 163 185 571 2580 2743 922 1199 1084 989 1432 2201 2057 1788 1310 545 429 401 419 124 3 3.4 days
DPO 758 857 1163 5257 5589 1880 1167 1055 962 1394 1380 1290 1121 822 482 380 355 371 253 7 7.0 days
Cash Conversion Cycle -524 -623 -548 -2640 -2812 -928 86 79 74 84 880 822 718 536 118 99 91 90 -90 35 34.7 days
Fixed Asset Turnover snapshot only 46.651
Operating Cycle snapshot only 41.7 days
Cash Velocity snapshot only 3.224
Capital Intensity snapshot only 0.580
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 60.9% 1.1% 7.8% 4.9% 1.6% 1.1% 72.3% 54.1% 50.6% 33.2% 22.4% 22.7% 24.7% 29.9% 36.0% 41.7% 45.9% 45.4% 94.1% 75.9% 75.92%
Net Income -83.9% -81.5% -0.7% 7.4% 2.1% 14.7% -34.3% -16.6% -15.8% -22.2% 8.3% 7.8% 39.9% 47.6% 60.8% 74.4% 75.5% 92.9% 4.0% -7.6% -7.57%
EPS -66.8% -78.9% 2.2% 11.2% 6.0% 18.0% -30.6% -14.4% -13.6% -20.0% 14.9% 15.7% 44.9% 52.0% 61.9% 75.5% 77.0% 93.3% 3.8% -6.6% -6.61%
FCF -83.9% -50.6% -4.9% 7.9% 4.2% -10.7% -12.9% 17.9% 24.2% 34.9% 40.4% 21.9% 30.8% 49.4% 45.4% 74.0% 1.2% 1.8% 7.2% 11.9% 11.92%
EBITDA -72.0% -60.7% 27.2% 34.7% 30.1% 46.7% -18.2% 1.1% -4.9% -28.1% 19.1% 14.5% 66.4% 80.4% 1.1% 1.5% 2.4% 4.5% 26.4% -8.9% -8.88%
Op. Income -53.6% -45.3% -1.7% 4.8% -3.0% 13.3% 16.5% 28.0% 37.8% 30.4% 30.1% 29.2% 46.6% 62.1% 97.5% 1.4% 1.9% 2.9% 135.1% -12.5% -12.51%
OCF Growth snapshot only 12.46%
Asset Growth snapshot only 4.84%
Debt Growth snapshot only -43.27%
Shares Change snapshot only 12.54%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 39.5% 73.6% 96.7% 1.0% 1.6% 1.7% 77.0% 82.4% 84.0% 81.0% 1.6% 1.2% 69.0% 53.5% 42.1% 38.9% 39.9% 36.0% 47.8% 45.1% 45.14%
Revenue 5Y 25.7% 39.0% 42.9% 43.4% 47.4% 51.1% 60.8% 71.2% 60.1% 70.9% 74.2% 73.6% 1.0% 1.0% 56.0% 60.2% 62.5% 62.1% 1.2% 94.2% 94.22%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y 37.6% 71.3% 95.1% 1.1% 1.7% 1.8% 80.8% 84.3% 85.8% 84.9% 1.7% 1.4% 74.2% 55.8% 43.0% 37.8% 38.8% 35.6% 47.9% -16.0% -16.01%
Gross Profit 5Y 24.6% 37.6% 44.7% 46.0% 50.3% 54.9% 62.3% 73.1% 61.3% 71.1% 74.5% 76.0% 1.1% 1.1% 57.8% 61.0% 63.3% 63.9% 1.2% 46.8% 46.83%
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y 23.4% 23.4% 58.8% 58.8% 58.8% 58.8% 46.4% 46.4% 46.4% 46.4% 15.6% 15.6% 15.6% 15.6% -5.9% -5.9% -5.9% -5.9% -2.2% -2.2% -2.22%
Assets 5Y 21.9% 21.9% 45.6% 45.6% 45.6% 45.6% 25.3% 25.3% 25.3% 25.3% 28.6% 28.6% 28.6% 28.6% 22.8% 22.8% 22.8% 22.8% 9.0% 9.0% 8.96%
Equity 3Y — — — — — — — — — — — — — — — — — — — — —
Book Value 3Y — — — — — — — — — — — — — — — — — — — — —
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.49 0.55 0.40 0.44 0.62 0.67 0.66 0.72 0.80 0.88 0.85 0.88 0.95 0.98 0.98 0.98 0.97 0.97 0.88 0.91 0.906
Earnings Stability 0.76 0.81 0.92 0.90 0.90 0.84 0.95 0.89 0.90 0.82 0.87 0.72 0.23 0.07 0.01 0.05 0.16 0.28 0.50 0.11 0.108
Margin Stability 0.96 0.95 0.96 0.91 0.95 0.95 0.97 0.90 0.96 0.97 0.97 0.90 0.94 0.95 0.97 0.98 0.98 0.97 0.97 0.56 0.561
Rev. Growth Consistency 1.00 1.00 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 1.00 0.97 0.99 0.94 0.86 0.93 0.94 0.91 0.97 0.97 0.84 0.81 0.50 0.50 0.50 0.50 0.20 0.50 0.500
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend — — — — — — — — — — — — — — — — — — — — —
Gross Margin Trend -0.00 0.05 0.04 0.14 0.07 0.05 0.05 0.10 0.03 0.02 0.02 0.00 0.00 -0.00 -0.01 -0.01 -0.01 -0.01 -0.00 -0.79 -0.789
FCF Margin Trend 3.60 3.97 3.87 2.78 1.22 0.93 3.72 2.71 1.07 0.69 0.47 0.37 0.38 0.40 0.33 0.32 0.34 0.32 0.58 0.50 0.504
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — 1.1% — —
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.79 0.68 0.77 0.82 0.77 0.88 0.65 0.58 0.51 0.47 0.42 0.49 0.57 0.45 0.59 0.48 -0.47 -5.66 1.25 -0.65 -0.647
FCF/OCF 1.01 1.01 1.02 1.02 1.01 1.01 1.01 1.01 1.01 1.02 1.02 1.02 1.02 1.02 1.02 1.04 0.94 0.95 0.99 0.99 0.991
FCF/Net Income snapshot only -0.641
CapEx/Revenue 1.6% 1.3% 1.5% 1.4% 1.0% 0.8% 0.5% 0.4% 0.4% 0.7% 0.7% 0.6% 0.5% 0.2% 0.2% 0.2% 0.2% 0.4% 0.3% 0.3% 0.31%
CapEx/Depreciation snapshot only 0.473
Accruals Ratio -0.18 -0.28 -0.09 -0.08 -0.10 -0.05 -0.15 -0.17 -0.21 -0.22 -0.25 -0.20 -0.12 -0.13 -0.07 -0.05 -0.10 -0.12 -0.13 -1.50 -1.502
Sloan Accruals snapshot only -0.118
Cash Flow Adequacy snapshot only 108.619
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — 0.0% — —
FCF Payout Ratio — — — — — — — — — — — — — — — — 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio — — — — — — — — — — — — — — — — — — 0.0% — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -0.0% -0.0% -2.0% -1.7% -2.5% -2.1% -0.2% -0.3% -0.5% -0.5% -0.2% -0.2% -0.0% -0.0% -0.0% -0.0% -0.0% -0.2% -0.2% -1.0% -0.99%
Total Shareholder Return -0.0% -0.0% -2.0% -1.7% -2.5% -2.1% -0.2% -0.3% -0.5% -0.5% -0.2% -0.2% -0.0% -0.0% -0.0% -0.0% -0.0% -0.2% -0.2% -1.0% -0.99%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.01 1.01 1.02 1.03 1.01 1.01 1.01 1.01 1.00 1.00 1.00 1.00 1.02 1.04 1.11 1.33 0.99 1.01 1.008
Interest Burden (EBT/EBIT) 1.20 1.26 1.48 1.58 1.64 1.94 1.68 1.85 1.81 1.89 1.92 2.02 3.23 4.87 -7.52 -1.10 -0.52 -0.08 0.77 1.20 1.196
EBIT Margin -2.26 -1.58 -0.78 -0.64 -0.62 -0.41 -0.54 -0.42 -0.43 -0.39 -0.36 -0.29 -0.12 -0.06 0.03 0.09 0.11 0.14 0.40 -0.43 -0.429
Asset Turnover 0.31 0.45 0.34 0.41 0.44 0.52 0.48 0.51 0.54 0.56 0.62 0.67 0.72 0.77 0.89 1.00 1.11 1.19 1.74 1.76 1.763
Equity Multiplier 26.86 26.86 -7.31 -7.31 -7.31 -7.31 -2.83 -2.83 -2.83 -2.83 -1.42 -1.42 -1.42 -1.42 -1.08 -1.08 -1.08 -1.08 -1.69 -1.69 -1.688
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-1.20 $-1.27 $-1.01 $-1.05 $-1.13 $-1.04 $-1.32 $-1.20 $-1.28 $-1.25 $-1.12 $-1.01 $-0.71 $-0.60 $-0.43 $-0.25 $-0.16 $-0.04 $1.20 $-1.89 $-1.89
Book Value/Share $-0.11 $-0.11 $-0.59 $-0.58 $-0.58 $-0.57 $-1.58 $-1.56 $-1.56 $-1.55 $-2.26 $-2.21 $-2.21 $-2.20 $-2.29 $-2.21 $-2.16 $-2.16 $-0.54 $-0.49 $-2.29
Tangible Book/Share $-0.11 $-0.11 $-0.59 $-0.58 $-0.58 $-0.57 $-1.58 $-1.56 $-1.56 $-1.55 $-2.26 $-2.21 $-2.21 $-2.20 $-2.29 $-2.21 $-2.16 $-2.16 $-0.54 $-0.49 $-0.49
Revenue/Share $0.44 $0.64 $0.86 $1.02 $1.10 $1.28 $1.45 $1.54 $1.62 $1.67 $1.65 $1.72 $1.85 $1.99 $2.17 $2.34 $2.54 $2.73 $3.99 $3.66 $3.66
FCF/Share $-0.96 $-0.87 $-0.79 $-0.87 $-0.88 $-0.93 $-0.87 $-0.70 $-0.66 $-0.59 $-0.48 $-0.50 $-0.42 $-0.27 $-0.26 $-0.12 $0.07 $0.22 $1.50 $1.21 $1.21
OCF/Share $-0.95 $-0.86 $-0.78 $-0.86 $-0.87 $-0.92 $-0.87 $-0.70 $-0.65 $-0.58 $-0.47 $-0.49 $-0.41 $-0.27 $-0.25 $-0.12 $0.08 $0.23 $1.51 $1.22 $1.22
Cash/Share $1.69 $1.68 $2.79 $2.75 $2.73 $2.73 $2.27 $2.25 $2.24 $2.24 $1.93 $1.89 $1.88 $1.88 $1.55 $1.49 $1.46 $1.46 $1.25 $1.13 $0.99
EBITDA/Share $-1.00 $-1.00 $-0.67 $-0.65 $-0.67 $-0.51 $-0.77 $-0.63 $-0.69 $-0.65 $-0.58 $-0.49 $-0.21 $-0.12 $0.06 $0.22 $0.29 $0.38 $1.60 $-1.55 $-1.55
Debt/Share $1.57 $1.56 $3.26 $3.21 $3.20 $3.19 $3.97 $3.93 $3.92 $3.91 $4.10 $4.00 $4.00 $3.99 $4.06 $3.91 $3.83 $3.83 $2.18 $1.97 $1.97
Net Debt/Share $-0.12 $-0.12 $0.47 $0.46 $0.46 $0.46 $1.70 $1.68 $1.68 $1.67 $2.17 $2.12 $2.11 $2.11 $2.51 $2.42 $2.37 $2.37 $0.92 $0.84 $0.84
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — -2.144
Altman Z-Prime snapshot only -8.030
Piotroski F-Score 4 5 6 6 6 5 2 2 2 3 4 4 3 3 3 3 4 5 7 4 4
Beneish M-Score 10.76 0.71 6.41 -0.98 -0.99 -0.89 -1.39 -1.57 -1.79 -1.87 -4.00 -3.70 -3.30 -3.34 256.20 256.33 256.05 255.95 -1.32 -9.40 -9.397
Ohlson O-Score snapshot only -2.367
Net-Net WC snapshot only $-0.95
EVA snapshot only $-309993340.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only B-
Credit Score 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 19.84 19.74 20.00 20.00 20.00 20.00 20.000
Credit Grade snapshot only 16
Credit Trend snapshot only 0.256
Implied Spread (bps) snapshot only 900.000
Industry Credit Rank snapshot only 26
Sector Credit Rank snapshot only 24

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms